
Joel Barrish
133 posts

Joel Barrish
@jcbarrish
Passionate about Drug Discovery and having an impact on patients in need. Cofounder & CSO at Jnana Tx











Congratulations to the 2023 ACS MEDI Hall of Fame inductees: Joel Barrish (@jcbarrish) Amy Newman (@anewman2014) and Donna Huryn (@DMHuryn). ACS Division of Medicinal Chemistry (@AcsMedi) will have the Hall of Fame ceremony and reception during the #ACSFall2023



Jnana is thrilled to announce a $107M Series C financing and initiation of our Phase 1 clinical trial in #PKU. The financing will support the PKU program and our preclinical programs in immune-mediated diseases and cancer. Learn more: bit.ly/3UYTiuc #BiotechNews

We are thrilled to be able to share data on our lead program with the PKU community as we head toward entering the clinic later this year.


Our team continues to grow at Jnana and we couldn’t be more excited to welcome Elena, Randy, Ellen, Roo, Greg, Jessica, Saumya, and John.

Celebrating the women of Jnana, today and every day – who are having impact across our organization, from our labs to our C-suite. Together we can all #BreakTheBias.


A human biology-based drug discovery effort coupled with a powerful binder-based chemoproteomics Platform is paving a path for PKU patients @jnanatx. And structure-guided optimization reveals the novel solutions that arise. Bravo @jcbarrish and team.

John Throup is joining Jnana at a pivotal inflection point - his leadership & expertise will be critical as we advance our lead program for #PKU into clinical dev & progress a promising pipeline of programs for hard-to-drug-targets in immune & oncology. bit.ly/3tK2EiX

Jnana CEO, @JoanneKotz, will be presenting at #JPM22 on our next gen chemoproteomic platform to pursue hard-to-drug targets. Learn more here: bit.ly/3zuatdo

Very thankful to work with an amazing group of people at Jnana. Happy thanksgiving!


